Clinical trials
Recurrence trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Recruiting | 19 |
| Unknown status | 18 |
| Active, not recruiting | 16 |
| Terminated | 11 |
| Not yet recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chang Gung Memorial Hospital | 11 |
| National Taiwan University Hospital | 11 |
| Novartis Pharmaceuticals | 9 |
| AstraZeneca | 7 |
| Pfizer | 5 |
| AbbVie | 4 |
| Regeneron Pharmaceuticals | 4 |
| China Medical University Hospital | 3 |
| Clovis Oncology, Inc. | 3 |
| Genmab | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 107 |
| Neoplasm Metastasis | 19 |
| Multiple Myeloma | 13 |
| Neoplasms | 12 |
| Head and Neck Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Neoplastic Cells, Circulating | 6 |
| Breast Neoplasms | 5 |
Trials
Showing 76 to 100 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.